December 3rd, 2024 (Shanghai) — We are glad to announce that Peter Joyce, the Chief Executive Officer of Greywolf Therapeutics, will be presenting at the ACCESS CHINA Partnering Forum @ JPM on January 7th-9th, and 21st-23rd, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.
About Greywolf Therapeutics
Greywolf Therapeutics is a clinical-stage based in Oxford, UK. Founded in 2017, the company has raised over 130 million USD from top venture capital funds and pharmaceutical companies. This funding has allowed Greywolf to spearhead a new therapeutic approach based on a first-of-its-kind antigen modulation platform. This is used to deliver a new class of treatments to improve the lives of people with cancers, autoimmune disorders, and infectious diseases.
About the speaker
Peter has over 16 years of experience in biomedical research leading drug discovery projects in immuno-oncology, rare genetic diseases and neurodegeneration. Alongside his role leading Greywolf, he is also a Co-founder of biotech companies Pathios Therapeutics and 35Bio. In his previous role at Vertex Pharmaceuticals, he led drug discovery projects, had responsibility for leading several target identification teams that led to multiple novel drug discovery projects, and was involved in delivering clinical drug candidates. He also pioneered the development of complex neurological assays suitable for assessing the functional impact of optimized compounds. Prior to Vertex, Peter was an MRC Research Fellow investigating the pathophysiology and underlying mechanisms of neurodegeneration and publishing multiple first and co-author publications. Peter holds a PhD in Biochemistry and Molecular Genetics from the University of Bristol and a BSc in Biochemistry.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum @ JPM is scheduled to be held on January 7th-9th, and 21st-23rd, 2025, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: January 7-9 (Live), and 21-23(VoD), 2025, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
Contact us:
To register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 